drugset / Trial / NCT01432171

Lacosamide in Preventing Seizures in Participants With Malignant Glioma

NCT01432171

RandomizedParallel-groupDouble-blindPrevention

Summary

This trial studies how well lacosamide works in preventing seizures in participants with malignant glioma. Anti-seizure drugs, such as lacosamide, may decrease abnormal electrical activity in the brain that plays a role in developing seizures.

Timeline

Start
2012-07-25
Primary completion
2017-06-20
Completion
2017-06-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Lacosamide Other / unclassified Oral

Indications